Analysis Trevi Therapeutics Inc (TRVI)
6/4/2024
Analysis of Trevi Therapeutics Inc (TRVI)
Trevi Therapeutics Inc (TRVI) has shown a downward trend in its stock price over the past few days. The Relative Strength Index (RSI) values have been hovering around 40-45, indicating a neutral to slightly bearish sentiment in the market.The Moving Average Convergence Divergence (MACD) indicator has been negative, with the MACD line below the signal line, suggesting a bearish trend. The MACD histogram has also been in the negative territory, indicating a potential continuation of the downward movement.
The Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) have all been above the current price, suggesting a bearish sentiment in the short term.
Overall, based on the technical indicators, Trevi Therapeutics Inc may continue to face downward pressure in the near future. Investors should closely monitor the stock for any potential reversal or trend change.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with a focus on operational efficiency and strategic investments.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching the highest value in 2023 at $352,583,000,000.
2. Current assets fluctuate each year, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2023 at $209,017,000,000.
4. Total liabilities have also been increasing, reaching the highest value in 2023 at $290,437,000,000.
5. Shareholders' equity has been fluctuating, with the highest value in 2019 at $90,488,000,000.
6. The company has been relying more on non-current assets to support its operations.
7. There is a significant amount of debt in the company's capital structure, both short-term and long-term.
8. The company has been investing heavily in machinery, furniture, and equipment over the years.
9. Retained earnings have been positive in most years, indicating profitability.
10. The company has been managing its cash and cash equivalents effectively, with fluctuations in other current assets.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company had an EPS estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuations metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive current ratio and a high total debt to equity ratio. The profit margin and operating margin are also healthy, indicating good financial performance. The company's fiscal year ends in September 2023, and it has shown a positive return on assets and return on equity.
Looking at stock statistics, the company has a low short ratio and a significant percentage of shares held by institutions. The stock price has fluctuated between a fifty-two-week low and high, with a positive change over the period.
Valuations metrics show a high PEG ratio and forward PE ratio, with the company's market capitalization and enterprise value being substantial. The price to book and price to sales ratios are also relatively high.
The stock price summary includes beta, moving averages, and the range of prices over the past year.
Lastly, dividends and splits information shows the company's dividend rates, payout ratio, and historical dividend yields, as well as details on past splits.
Income statement 💸
These are the revenues. Here are the conclusions:1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. Despite the increase in sales, the cost of goods sold has also been rising, indicating a potential decrease in profit margins.
3. The company's gross profit has fluctuated over the years, reaching its peak in 2023 at $169.1 billion.
4. Operating income has shown an upward trend, with the company generating higher operating profits in recent years.
5. Net income has also been increasing annually, from $57.4 billion in 2020 to $97 billion in 2023.
6. Earnings per share (EPS) have shown a slight fluctuation but have generally increased over the years.
7. The company has been able to maintain a stable number of outstanding shares, which is important for calculating earnings per share accurately.
8. Overall, the financial performance of the company in terms of revenue and income has been positive, with consistent growth in sales and profitability.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average EPS estimate is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This also indicates growth from the EPS of $1.35 in the same quarter last year.
3. Looking at the estimates for the current year ending on September 30, 2024, the average EPS estimate is $6.10, ranging from a low estimate of $5.95 to a high estimate of $6.41. This reflects an increase from the EPS of $5.67 for the previous year.
4. For the next year ending on September 30, 2025, the average EPS estimate is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This suggests a slight improvement from the EPS of $6.10 in the current year.
Overall, the analysts' estimates point towards a positive trend of increasing earnings per share for the company in both the short term and the long term.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 25.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 38.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 38.
Overall, the analysts are forecasting moderate sales growth for both the upcoming quarters and the next fiscal year, indicating a positive outlook for the company's performance. The increase in the number of analysts providing estimates for the annual sales also suggests a growing interest in the company's financial performance.
Growth estimates
Based on the consensus estimates provided:- The current year growth rate is 7.6%
- The next quarter growth rate is 5.1%
- The current quarter growth rate is 5.1%
- The next year growth rate is 9.7%
- The next 5 years compound annual growth rate (CAGR) is 9.7%
- The past 5 years compound annual growth rate (CAGR) is 20.1%
It can be observed that the company is expected to experience a higher growth rate in the future compared to the past, with a significant decrease in growth rate from the past 5 years to the next 5 years. The current and next quarter growth rates are the same, indicating a consistent performance in the short term.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25
- Currency: USD
Based on these forecasts, we can see that the analysts have a wide range of opinions on the future price of the security, with the low end at $164, the high end at $275, and the average at $204.58. The current price of the security is $192.25, which is below the median and average forecasted prices. Investors should consider these forecasts along with other factors when making decisions about buying or selling the security.
MACD of TRVI
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
